Viatris Initiates Class II Voluntary Recall of Sevoflurane Anesthetic Due to Manufacturing Deviation

Viatris Pharmaceuticals Japan has begun a Class II voluntary recall of specific lots of its Sevoflurane Inhalation Solution 'VTRS' anesthetic. The recall was initiated after the discovery that these lots were manufactured using an unapproved production parameter, posing a potential patient safety concern.